Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026)

Ocular Therapeutix's Other Operating Expenses history runs 14 years deep, the most recent figure standing at $17.9 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 59.41% year-over-year to $17.9 million in Q1 2026; TTM through Mar 2026 was -$72.8 million, a 404.41% decrease from a year earlier, with the FY2025 full-year figure at $60.5 million, up 28.13% from the prior year.
• Other Operating Expenses grew to $17.9 million in Q1 2026 per OCUL's latest filing, from -$90.8 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $44.1 million in Q1 2025 and bottomed at -$90.8 million in Q4 2025.
• The 5-year median for Other Operating Expenses is $12.3 million (2023), against an average of $5.7 million.
• Across the five-year window, Other Operating Expenses sank 349.28% in 2024 and soared 99.99% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $25.1 million in 2022, then retreated by 29.91% to $17.6 million in 2023, then plunged by 349.28% to -$43.8 million in 2024, then tumbled by 107.14% to -$90.8 million in 2025, then jumped by 119.72% to $17.9 million in 2026.
• Per Business Quant, the three latest OCUL Other Operating Expenses figures stand at $17.9 million (Q1 2026), -$90.8 million (Q4 2025), and $29000.0 (Q2 2025).